文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

个体随机试验中协变量调整方法的规划:实用指南。

Planning a method for covariate adjustment in individually randomised trials: a practical guide.

作者信息

Morris Tim P, Walker A Sarah, Williamson Elizabeth J, White Ian R

机构信息

MRC Clinical Trials Unit at UCL, London, UK.

Department of Medical Statistics, LSHTM, London, UK.

出版信息

Trials. 2022 Apr 18;23(1):328. doi: 10.1186/s13063-022-06097-z.


DOI:10.1186/s13063-022-06097-z
PMID:35436970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9014627/
Abstract

BACKGROUND: It has long been advised to account for baseline covariates in the analysis of confirmatory randomised trials, with the main statistical justifications being that this increases power and, when a randomisation scheme balanced covariates, permits a valid estimate of experimental error. There are various methods available to account for covariates but it is not clear how to choose among them. METHODS: Taking the perspective of writing a statistical analysis plan, we consider how to choose between the three most promising broad approaches: direct adjustment, standardisation and inverse-probability-of-treatment weighting. RESULTS: The three approaches are similar in being asymptotically efficient, in losing efficiency with mis-specified covariate functions and in handling designed balance. If a marginal estimand is targeted (for example, a risk difference or survival difference), then direct adjustment should be avoided because it involves fitting non-standard models that are subject to convergence issues. Convergence is most likely with IPTW. Robust standard errors used by IPTW are anti-conservative at small sample sizes. All approaches can use similar methods to handle missing covariate data. With missing outcome data, each method has its own way to estimate a treatment effect in the all-randomised population. We illustrate some issues in a reanalysis of GetTested, a randomised trial designed to assess the effectiveness of an electonic sexually transmitted infection testing and results service. CONCLUSIONS: No single approach is always best: the choice will depend on the trial context. We encourage trialists to consider all three methods more routinely.

摘要

背景:长期以来,在确证性随机试验的分析中一直建议考虑基线协变量,主要的统计学依据是这会提高检验效能,并且当随机化方案使协变量平衡时,能够对实验误差进行有效估计。有多种方法可用于考虑协变量,但尚不清楚如何在它们之间进行选择。 方法:从撰写统计分析计划的角度出发,我们考虑如何在三种最有前景的主要方法之间进行选择:直接调整、标准化和治疗逆概率加权。 结果:这三种方法在渐近效率、因协变量函数指定错误而导致效率损失以及处理设计平衡方面相似。如果目标是边际估计量(例如,风险差或生存差),则应避免直接调整,因为它涉及拟合存在收敛问题的非标准模型。IPTW最有可能实现收敛。IPTW使用的稳健标准误在小样本量时是反保守的。所有方法都可以使用类似的方法来处理协变量数据缺失的情况。对于结局数据缺失的情况,每种方法都有自己在所有随机分组人群中估计治疗效果的方式。我们在对GetTested(一项旨在评估电子性传播感染检测及结果服务有效性的随机试验)的重新分析中阐述了一些问题。 结论:没有一种方法总是最佳的:选择将取决于试验背景。我们鼓励试验者更常规地考虑所有这三种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915e/9014627/16907c0e00eb/13063_2022_6097_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915e/9014627/16907c0e00eb/13063_2022_6097_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/915e/9014627/16907c0e00eb/13063_2022_6097_Fig1_HTML.jpg

相似文献

[1]
Planning a method for covariate adjustment in individually randomised trials: a practical guide.

Trials. 2022-4-18

[2]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[3]
An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.

BMC Med Res Methodol. 2020-3-23

[4]
A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.

Trials. 2023-1-6

[5]
Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.

BMC Med Res Methodol. 2022-4-13

[6]
Variance reduction in randomised trials by inverse probability weighting using the propensity score.

Stat Med. 2013-9-30

[7]
Covariate adjustment in randomized clinical trials with missing covariate and outcome data.

Stat Med. 2023-9-30

[8]
Covariate adjustment in Bayesian adaptive randomized controlled trials.

Stat Methods Med Res. 2024-3

[9]
Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.

Clin Trials. 2021-10

[10]
When does adjusting covariate under randomization help? A comparative study on current practices.

BMC Med Res Methodol. 2024-10-26

引用本文的文献

[1]
Tackling control risk problems in non-inferiority trials.

BMJ Med. 2025-6-15

[2]
Effect of aspirin on small for gestational age neonates in pregnancies at high-risk for preeclampsia: a secondary analysis of a cluster randomised clinical trial.

Lancet Reg Health West Pac. 2025-6-5

[3]
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.

Contemp Clin Trials. 2025-8

[4]
Impact of Aspirin on Timing of Birth in Pregnancies With Clinical Manifestations of Placental Dysfunction: Evidence From a Multicentre Randomised Clinical Trial.

BJOG. 2025-5-14

[5]
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.

BMJ. 2025-4-28

[6]
Interpreting the meaningfulness of treatment effects estimated in parallel groups designs: comment on Trigg et al.

Qual Life Res. 2025-3-28

[7]
A Spline-Based Approach to Smoothly Constrain Hazard Ratios With a View to Apply Treatment Effect Waning.

Stat Med. 2025-3-15

[8]
Multicentre, double-blind, randomised controlled clinical trial comparing intermittent cefoxitin administration versus loading bolus followed by continuous infusion for the prevention of surgical site infection in colorectal surgery: the PROPHYLOXITIN study protocol.

BMJ Open. 2025-1-28

[9]
Estimating relative risks and risk differences in randomised controlled trials: a systematic review of current practice.

Trials. 2025-1-2

[10]
Re-analysis of data from cluster randomised trials to explore the impact of model choice on estimates of odds ratios: study protocol.

Trials. 2024-12-18

本文引用的文献

[1]
On the logic of collapsibility for causal effect measures.

Biom J. 2022-2

[2]
Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets.

Biom J. 2021-3

[3]
Propensity score weighting for covariate adjustment in randomized clinical trials.

Stat Med. 2021-2-20

[4]
Analysis of multicenter clinical trials with very low event rates.

Trials. 2020-11-9

[5]
Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide.

Stat Med. 2020-9-20

[6]
An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.

BMC Med Res Methodol. 2020-3-23

[7]
Extending inferences from a randomized trial to a new target population.

Stat Med. 2020-6-30

[8]
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners.

BMJ. 2019-10-23

[9]
Ideal vs. real: a systematic review on handling covariates in randomized controlled trials.

BMC Med Res Methodol. 2019-7-3

[10]
On the collapsibility of measures of effect in the counterfactual causal framework.

Emerg Themes Epidemiol. 2019-1-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索